Back to School: How biopharma can reboot drug development. Access exclusive analysis here
As part of the transaction, GENZ's shareholders also approved the issuance of a new class of common stock (GENZL) that will
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury